Literature DB >> 23199867

Minimally invasive forefoot surgery: a cadaveric study.

Vivekanandan Dhukaram1, Anna Prasthofer Chapman, Piyush Kumar Upadhyay.   

Abstract

BACKGROUND: Minimally invasive surgery (MIS) aims to improve cosmesis and minimize soft tissue disruption by using small skin incisions. When using MIS in the forefoot, there is concern about iatrogenic neurovascular and tendon damage. The aim of this anatomical study was to assess the risk of iatrogenic injury while performing MIS techniques.
METHODS: Ten normal cadaveric feet were used. All of the procedures were performed in a cadaveric lab using a mini-C-arm by two surgeons: a consultant who has attended a cadaveric MIS training course but does not perform MIS in his regular practice (eight feet) and a registrar (resident) who was supervised by the same consultant (two feet). In each foot, the surgeon performed a lateral release, a minimally invasive chevron and Akin (MICA) procedure for the correction of hallux valgus, and a minimally invasive distal metatarsal extra-articular osteotomy (DMO). Each foot was then dissected to identify any neurovascular or tendon injury and photographed.
RESULTS: The dorsal medial cutaneous and the plantar interdigital nerves were intact in all specimens. There was no apparent damage to the arterial plexus supplying the first metatarsal head. No flexor or extensor tendon injuries were identified. On examination of the osteotomies, the cuts were found not to be in the desired plane. In both MICA and DMO, the dissection also revealed some intact soft tissue at the osteotomy site, which may preserve vascularity and add stability to the osteotomy.
CONCLUSIONS: Although there has been concern regarding neurovascular and tendon injury, the findings were consistent with minimal risk, which is consistent with reports in the literature. This study also reflects the challenges associated with performing the osteotomy in the desired plane, which may be related to the learning curve. CLINICAL RELEVANCE: This cadaveric study has demonstrated a minimal risk of neurovascular and tendon injury associated with minimally invasive techniques in the forefoot. However, the study emphasizes the need for excellent three-dimensional anatomy and suggests additional cadaveric training prior to attempting these techniques in clinical practice.

Entities:  

Mesh:

Year:  2012        PMID: 23199867     DOI: 10.3113/FAI.2012.1139

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  6 in total

Review 1.  [Minimally invasive correction of lesser toe deformities and treatment of metatarsalgia].

Authors:  M Thomas; M Jordan
Journal:  Oper Orthop Traumatol       Date:  2018-05-08       Impact factor: 1.154

2.  The Correction Potential of the Lateral Release of the Hallux Valgus: A Comparative Anatomical Study of Minimally Invasive Versus Open Surgical Technique Using a Dorsal Approach.

Authors:  Kajetan Klos; Mark Lenz; Gunther O Hofmann; Wiebke Schubert; Matthias Knobe; Klaus Edgar Roth; Paul Simons; Matthias Aurich
Journal:  Indian J Orthop       Date:  2022-01-13       Impact factor: 1.033

3.  Geometric analysis of indications for minimally invasive distal metatarsal osteotomy in treatment of hallux valgus.

Authors:  Blaž Mavčič
Journal:  J Orthop Surg Res       Date:  2015-10-17       Impact factor: 2.359

4.  Minimally invasive surgery for pedal digital deformity: an audit of complications using national benchmark indicators.

Authors:  Mark Gilheany; Omar Baarini; Dean Samaras
Journal:  J Foot Ankle Res       Date:  2015-04-21       Impact factor: 2.303

Review 5.  The pathology and management of lesser toe deformities.

Authors:  Karan Malhotra; Kinner Davda; Dishan Singh
Journal:  EFORT Open Rev       Date:  2017-03-13

6.  3rd generation MICA with the "K-wires-first technique" - a step-by-step instruction and preliminary results.

Authors:  Andreas Toepfer; Michael Strässle
Journal:  BMC Musculoskelet Disord       Date:  2022-01-18       Impact factor: 2.362

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.